What is your approach to post-operative prophylactic anticoagulation for patients undergoing minimally invasive surgery for gynecologic malignancies?

Recommendation:

This is a great question; one our group has recently been discussing. My current practice is to advise patients with gynecologic malignancies undergoing minimally invasive surgery (MIS) to receive extended prophylaxis (4-week course of apixaban) depending on individual risk factors. Admittedly, I have a low threshold to administer prophylaxis in these patients.

Background:

The rate of venous thromboembolism (VTE) following MIS in patients with gynecologic malignancies is generally r...